Yonsei Med J.  2001 Jun;42(3):357-359. 10.3349/ymj.2001.42.3.357.

Acute Eosinophilic Pneumonia Associated with Amitriptyline in a Hemodialysis Patient

Affiliations
  • 1Institute of Kidney Disease, Yonsei University College of Medicine, Seoul, Korea.
  • 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. hyl@yumc.yonsei.ac.kr
  • 3Department of Internal Medicine, Eulji University College of Medicine, Taejeon, Korea.

Abstract

Drugs are well known causes of eosinophilic lung disease. In many patients, drug-induced eosinophilic lung disease presents with transient eosinophilic infiltrates that disappear after discontinuation of the drug. Some patients, however, experience a fulminant, acute eosinophilia-like disease. Recently, we experienced a case of amitriptyline-associated acute eosinophilic pneumonia with respiratory failure in a diabetic hemodialysis patient. Eight days after treatment with amitriptyline, sudden fever, chill, dry cough and dyspnea developed. Subsequently, multiple patch consolidations appeared on the chest radiographs. Bronchoalveolar lavage (BAL), established a diagnosis of acute eosinophilic pneumonia. After immediate discontinuation of amitriptyline, a rapid clinical and radiological improvement was observed. The present case indicates that the possibility of acute eosinophilic pneumonia should be fully considered in dialysis patients developing unexplained respiratory symptoms while on amitriptyline therapy.

Keyword

Amitriptyline; eosinophilic pneumonia; hemodialysis

MeSH Terms

Acute Disease
Adult
Amitriptyline/*adverse effects
Antidepressive Agents, Tricyclic/*adverse effects
Female
Human
Pulmonary Eosinophilia/*etiology
*Renal Dialysis
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr